La AEMPS informa del cambio de dosificación de Rybelsus (semaglutida) y los posibles errores de medicación

El CGCOF y la AEMPS lanzan una campaña para fomentar la notificación de reacciones adversas de los medicamentos

Safety population size and duration of exposure prior to approval of new medicines: A database analysis of medicines centralised approved in the European Union between 2011 and 2023

Veterinary drug residues in food: what’s the latest in the EU?

 

IXCHIQ Chikungunya vaccine: updates to restrictions of use following safety review

Las especialistas en Farmacología Clínica, claves para garantizar la seguridad de los medicamentos y la equidad en los ensayos clínicos

What drugs are safe during pregnancy? There’s a shocking lack of data

Impact of the amended CIR 520/2012 to UK authorised products

Updates to CIR 520/2012 – Information for UK Marketing Authorisation Holders

Clinicians and pharmacists – Are your patients aware of the risks of buying melatonin online?

Europa se estanca en la reducción de residuos de medicamentos veterinarios: más controles, pero mismos resultados

EsSalud refuerza la vigilancia de medicamentos y dispositivos médicos para prevenir riesgos en pacientes

Phosphorescent supramolecular systems for medicine anticounterfeiting

Seis boticas clausuradas por venta irregular de medicamentos

Prescribing Patterns of Potentially Inappropriate CNS-Active Medications in Older Adults

Large language models-powered agentic AI design and implementation in pharmacovigilance—a narrative review

Older Patients Have Specific Risks for GLP-1 Use

Artificial Intelligence in Food Allergy and Drug Allergy

Respiratory drugs and psychiatric adverse events in children and adolescents: a pharmacovigilance study based on the FAERS database

Proton Pump Inhibitors and Disproportionate Reporting of Acute Kidney Injury and Tubulointerstitial Nephritis: A FAERS Pharmacovigilance Study, 2020–2025

Safety Assessment of Budesonide/Formoterol: Real-World Pharmacovigilance Analysis Using the FAERS, JADER, and CVAR Databases

Real-World Sodium Fluoride Safety Signals: Dual-Database Pharmacovigilance

Assessing patient risk, benefit, and outcomes in drug development: a decade of sorafenib clinical trials

La AEMPS informa sobre el riesgo de acontecimientos adversos en animales de compañía por contacto con medicamentos hormonales tópicos de humanos

Computational modelling and network medicine in drug toxicology and clinical pharmacovigilance

When Silence Signals Safety: Governance and Responsibility in AI-Enabled Prescription Verification

Update of the statement on safety of cannabidiol as a novel food

Por qué la seguridad está redefiniendo la política del medicamento

FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs

Adverse Drug Reactions to Biologic Drugs in the Treatment of Psoriasis

Evaluating Pharmacists’ Role In Veterinary Medication Management and Education

Drug Safety Agents Using Graphs and Ontologies

Signal to Safety: Unpacking the Pharmacovigilance Program of India (PVPI)

Suspect screening strategy reveals that illegal addition of drugs to fishery inputs is the main cause of drug residue problems in quality and safety of aquatic products in China

Excipient toxicity and tolerability in self-emulsifying drug delivery systems: insights from cell-based assays

Prevalence and Trends of Adulterants Detected in Products Sampled by Sarawak Pharmacy Enforcement Branch

Disproportionality analysis of semaglutide-associated bile-duct cancer: A vigibase study

Drug-associated tongue discoloration: a comprehensive assessment of USFDA adverse event reporting system using disproportionality analysis

Sex-disparate safety profile of Obinutuzumab: a pharmacovigilance analysis using the FDA adverse event reporting system

Rapid analytical screening of pharmaceuticals using UV-activated fluorescence fingerprints